Cargando…

Subclinical atherosclerosis and silent myocardial ischaemia in patients with type 2 diabetes: a protocol of a clinico-observational study

INTRODUCTION: Atherosclerotic cardiovascular disease is a significant modifiable complication in patients with diabetes and subclinical atherosclerosis is considered a surrogate marker of future vascular events. The clustering of cardiometabolic-risk factors in patients with diabetes and cardiovascu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prasad, D S, Kabir, Zubair, Devi, K Revathi, Dash, A K, Das, B C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2014
Materias:	Cardiac Risk Factors and Prevention
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195927/ https://www.ncbi.nlm.nih.gov/pubmed/25332812 http://dx.doi.org/10.1136/openhrt-2014-000100

Ejemplares similares

Cardiovascular drugs attenuated myocardial resistance against ischaemia-induced and reperfusion-induced injury in a rat model of repetitive occlusion
por: Gatzke, Nora, et al.
Publicado: (2018)

Subclinical sleep apnoea and plasma levels of endothelin-1 among young and healthy adults
por: Schoen, Tobias, et al.
Publicado: (2017)

Applying the ordinal model of atherosclerosis to imaging science: a brief review
por: Groenendyk, Jacob W, et al.
Publicado: (2018)

Resting heart rate and incident venous thromboembolism: the Multi-Ethnic Study of Atherosclerosis
por: Awotoye, Josephine, et al.
Publicado: (2020)

Myocardial infarction, ST-elevation and non-ST-elevation myocardial infarction and modelled daily pollution concentrations: a case-crossover analysis of MINAP data
por: Butland, Barbara K, et al.
Publicado: (2016)

Association of ambulatory heart rate and atherosclerosis risk factors with blood pressure in young non-hypertensive adults
por: Cheng, Cynthia, et al.
Publicado: (2016)

Hepatocyte growth factor is associated with greater risk of extracoronary calcification: results from the multiethnic study of atherosclerosis
por: Ogunmoroti, Oluseye, et al.
Publicado: (2022)

β-Blockers in hypertension, diabetes, heart failure and acute myocardial infarction: a review of the literature
por: DiNicolantonio, James J, et al.
Publicado: (2015)

Risk of myocardial infarction after invasive outpatient procedures
por: Sen, Abhijit, et al.
Publicado: (2023)

Associations between short-term exposure to PM(2.5) and cardiomyocyte injury in myocardial infarction survivors in North Carolina
por: Wyatt, Lauren, et al.
Publicado: (2022)

Acute myocardial infarction and influenza: a meta-analysis of case–control studies
por: Barnes, Michelle, et al.
Publicado: (2015)

The impact of passive and active smoking on inflammation, lipid profile and the risk of myocardial infarction
por: Attard, Ritienne, et al.
Publicado: (2017)

Sibling history is associated with heart failure after a first myocardial infarction
por: Glinge, Charlotte, et al.
Publicado: (2020)

Newly diagnosed diabetes and outcomes after acute myocardial infarction in young adults
por: Ding, Qinglan, et al.
Publicado: (2021)

Association between treatment for erectile dysfunction and death or cardiovascular outcomes after myocardial infarction
por: Andersson, Daniel P, et al.
Publicado: (2017)

Comparative effectiveness of ACE inhibitors and angiotensin receptor blockers in patients with prior myocardial infarction
por: Ko, Dennis, et al.
Publicado: (2019)

Interstitial lung disease is a risk factor for ischaemic heart disease and myocardial infarction
por: Clarson, Lorna Elise, et al.
Publicado: (2020)

Association of cardiac rehabilitation and health-related quality of life following acute myocardial infarction
por: Hurdus, Ben, et al.
Publicado: (2020)

Blood pressure target achievement and antihypertensive medication use in women and men after first-ever myocardial infarction: the Tromsø Study 1994–2016
por: Hopstock, Laila A, et al.
Publicado: (2018)

Association between exercise load, resting heart rate, and maximum heart rate and risk of future ST-segment elevation myocardial infarction (STEMI)
por: Helleryd, Edvin, et al.
Publicado: (2023)

Cardiac rehabilitation using the Family-Centered Empowerment Model versus home-based cardiac rehabilitation in patients with myocardial infarction: a randomised controlled trial
por: Vahedian-Azimi, Amir, et al.
Publicado: (2016)

Loneliness and social isolation as risk factors for coronary heart disease and stroke: systematic review and meta-analysis of longitudinal observational studies
por: Valtorta, Nicole K, et al.
Publicado: (2016)

Web-based cardiac REhabilitatioN alternative for those declining or dropping out of conventional rehabilitation: results of the WREN feasibility randomised controlled trial
por: Houchen-Wolloff, Linzy, et al.
Publicado: (2018)

Does the timing of cardiac rehabilitation impact fitness outcomes? An observational analysis
por: Fell, Jennifer, et al.
Publicado: (2016)

Does cardiac rehabilitation meet minimum standards: an observational study using UK national audit?
por: Doherty, Patrick, et al.
Publicado: (2017)

Observational study of the relationship between volume and outcomes using data from the National Audit of Cardiac Rehabilitation
por: Doherty, Patrick, et al.
Publicado: (2015)

Impact of risk factors for major cardiovascular diseases: a comparison of life-time observational and Mendelian randomisation findings
por: Lind, Lars, et al.
Publicado: (2021)

Harnessing digital health to optimise the delivery of guideline-based cardiac rehabilitation during COVID-19: an observational study
por: Gibson, Irene, et al.
Publicado: (2023)

The importance of early life family factors in the association between cardiovascular risk factors and early cardiovascular mortality
por: Kjøllesdal, Marte K R, et al.
Publicado: (2017)

Statin treatment and LDL-cholesterol treatment goal attainment among individuals with familial hypercholesterolaemia in primary care
por: Iyen, Barbara, et al.
Publicado: (2021)

Dynamic cycling in atrial size and flow during obstructive apnoea
por: Pressman, Gregg S, et al.
Publicado: (2016)

Outcomes of an integrated community-based nurse-led cardiovascular disease prevention programme
por: Connolly, S B, et al.
Publicado: (2017)

Comparing the performance of the novel FAMCAT algorithms and established case-finding criteria for familial hypercholesterolaemia in primary care
por: Qureshi, Nadeem, et al.
Publicado: (2021)

Systematic screening for cardiovascular risk at pharmacies
por: Rohla, Miklos, et al.
Publicado: (2016)

Pregnancy-related cardiovascular conditions and outcomes in a United States Medicaid population
por: Marschner, Simone, et al.
Publicado: (2022)

Time-based measures of treatment effect: reassessment of ticagrelor and clopidogrel from the PLATO trial
por: Bellavia, Andrea, et al.
Publicado: (2017)

Phosphodiesterase type-5 inhibitor use in type 2 diabetes is associated with a reduction in all-cause mortality
por: Anderson, Simon G, et al.
Publicado: (2016)

Coronary heart disease and stroke in the Sami and non-Sami populations in rural Northern and Mid Norway—the SAMINOR Study
por: Siri, Susanna R A, et al.
Publicado: (2020)

Prevalence and RIsk factors for Silent Myocardial ischemia (PRISM): A clinico observational study in patients of type 2 diabetes
por: Prasad, D.S., et al.
Publicado: (2019)

Incremental prognostic value of visually estimated coronary artery calcium in patients undergoing positron emission tomography imaging
por: Selvaraj, Senthil, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sqrvg9fimm5fhbip3ggdmf1jjg